DATE
May 21st and 22nd, 2010
VENUE
MaRS Centre, 101 College Street, South Tower, Toronto, Ontario, Canada more
PURPOSE
To take an international multi-stakeholder approach to discuss stem cell translational barriers and to assist in defining a blueprint for stem cell innovation, translation and commercialization for spinal cord injury and related degenerative disorders of the central nervous system.
WHO SHOULD ATTEND
Academic and industry researchers, clinicians, health regulators, public policy officials, bio-ethicists, government, non-governmental organizations, consumers, and patient advocacy groups, business development officers and technology transfer officers, legal representatives. more
MAJOR DELIVERABLE
A Delphi consensus building effort will be launched in parallel to the GBC to yield a manuscript for peer-reviewed publication to present international agreement concerning issues impeding the safe and efficacious translation of stem cells from the laboratory into the clinic
MEETING CHAIR
Dr. Michael G. Fehlings, M.D., Ph.D., FRCSC, FACS; Krembil Chair in Neural Repair & Regeneration at Toronto Western Hospital, Professor of Neurosurgery at University of Toronto; Acute Practice Network Lead for the SCI Solutions Network
